Legal 500
Log in or register
  • Rankings

    • Jurisdictions
    • Submissions
    • Future Lawyers
  • Firms & Lawyers

    • Service Providers
    • Barristers’ Sets
    • Networks
    • Interview with…
  • In-House

    • In-House Content
    • GC Powerlist
  • Knowledge Centre

    • Data Products
    • Legal Business
    • Market Intelligence
    • About us

      • Legal 500
      • FAQs
      • Marketing
      • Careers
      • Trust Centre
      • Contact us
  • Comparative Guides
  • Events
  • Legal 500 TV

About us

  • Legal 500
  • FAQs
  • Marketing
  • Careers
  • Trust Centre
  • Contact us
  • Deutschland DE
  • Paris FR
  • Rankings

    • Jurisdictions
    • Submissions
    • Future Lawyers
  • Firms & Lawyers

    • Service Providers
    • Barristers’ Sets
    • Networks
    • Interview with…
  • In-House

    • In-House Content
    • GC Powerlist
  • Knowledge Centre

    • Data Products
    • Legal Business
    • Market Intelligence
    • About us

      • Legal 500
      • FAQs
      • Marketing
      • Careers
      • Trust Centre
      • Contact us
  • Comparative Guides
  • Events
  • Legal 500 TV

About us

  • Legal 500
  • FAQs
  • Marketing
  • Careers
  • Trust Centre
  • Contact us
  • Deutschland DE
  • Paris FR

© 2026 Legalease Ltd. All rights reserved

Registered company in England & Wales No. 02427356 VAT GB 321 5727 22

Registered address: 188 Fleet Street, London, EC4A 2AG

  • Legal 500 Trust Centre
  • Contact Us
  • home
  • Market Intelligence
  • Search

442 results found

Use advanced search filters to refine your search

2 filters applied

Advanced search filters

Topics
Countries
Contributor

Start typing to add contributors

Content type
Show options
  • Article

    Merger Of Torrent Pharmaceuticals With JB Chemicals: En Route To Becoming Second-Largest Player In Pharma Industry

    On 29 June 2025,1 Torrent Pharmaceuticals Limited("Torrent") announced a strategic transaction to acquire a controlling stake in J.B. Chemicals & Pharmaceuticals Limited("JB Pharma"), followed by the proposed...
    IndiaFood, Drugs, Healthcare, Life Sciences
    Acuity Law
    Acuity Law
  • Article

    Coined, Not Derived: Dr. Reddy’s Laboratories v. Razenta Pharmaceuticals And The Limits Of The “Named After The Molecule” Defence

    The Delhi High Court (Justice Jyoti Singh) allowed a cancellation petition under Section 57 and struck DAPLOGIN (Class 5) from the Register, finding it deceptively similar to Dr. Reddy’s earlier coined mark DAPLO for a diabetes drug with the same active ingredient, dapagliflozin.
    IndiaIntellectual Property
S.S. Rana & Co.
S.S. Rana & Co.
  • Article

    Implications Of Section 3(d) Of The Patents Act

    An invention has to satisfy the conditions of Novelty, Inventive step, and Industrial Applicability in order to be patentable in India, just like any other jurisdiction.
    IndiaIntellectual Property
    L. S. Davar & Co.
    L. S. Davar & Co.
  • Article

    Impact Of GST Rate Changes On The Health And Pharma Sector

    The GST Council in 56th meeting held in New Delhi on 03.09.2025 introduced significant reforms aimed at making healthcare more affordable and accessible to common man.
    IndiaTax
    Lakshmikumaran & Sridharan
    Lakshmikumaran & Sridharan
  • Article

    Beware Pharmaceutical Companies- CCI Penalizes Alkem Laboratories Ltd. (ALKEM) For Bowing Down To Pressure Of All Kerala Chemists And Druggists Association By Stopping Supplies To A Local Chemist

    The CCI, vide its recent order dated December 1, 2015, has penalized All Kerala Chemists and Druggists Association and Alkem Laboratories Limited for limiting and controlling the supply of medicines in Kerala.
    IndiaAntitrust/Competition Law
    Vaish Associates Advocates
    Vaish Associates Advocates
  • Article

    Impact Of Medical Devices (Amendment) Rules 2020 On PPE And PPE Components

    With the prevalence of COVID-19 and the consequent lockdown, various entities, Small Scale Industries, MSMEs, Start-ups have entered into the manufacturing of PPE kits, ...
    IndiaFood, Drugs, Healthcare, Life Sciences
    SUO Law
    SUO Law
  • Article

    The DNA Technology (Use And Application) Regulation Bill 2019

    In a landmark decision, the Lok Sabha, on January 08, 2019, passed the "DNA Technology (Use and Application) Regulation Bill - 20193" (here after referred as "Bill").
    IndiaFood, Drugs, Healthcare, Life Sciences
    S&A Law Offices
    S&A Law Offices
  • Article

    The Medical Devices Rules, 2017 – Industry Implications And Action Required

    The ‘medical devices' sector has largely enjoyed a free hand from the regulators in India, as the sphere has largely gone unregulated thus far.
    IndiaFood, Drugs, Healthcare, Life Sciences
    Vaish Associates Advocates
    Vaish Associates Advocates
  • Article

    Biological Resources Are Property Of The Nation; Divya Pharmacy's Challenge To Fair And Equitable Benefit Sharing Dismissed

    On December 21, 2018, a Single Judge Bench of the Uttarakhand High Court ruled that Divya Pharmacy, an Indian company which was engaged in the manufacturing of Ayurvedic medicines, would be subjected to ...
    IndiaFinance and Banking
    S.S. Rana & Co.
    S.S. Rana & Co.
  • Article

    Department Of Pharmaceuticals (DoP) Releases Final Guidance On Procurement Of Medical Devices Under Public Procurement Order (PPO), 2017

    On May 18, 2018, the Department of Pharmaceuticals (DoP), Ministry of Chemicals and Fertilizers, released final guideline for implementation of provisions of the Public Procurement ...
    IndiaFood, Drugs, Healthcare, Life Sciences
    S&A Law Offices
    S&A Law Offices
  • Article

    Parliamentary Standing Committee Report On India's Intellectual Property Rights Regime

    The Parliamentary Standing Committee on Commerce, for its 161st report, has undertaken a review of the Intellectual Property Rights regime in India and presented...
    IndiaIntellectual Property
    S&A Law Offices
    S&A Law Offices
  • Article

    Indirect Tax E-Bulletin – July 2021

    CBIC has issued various clarifications with respect to Order dated 27 April 2021 issued by Supreme Court extending period(s) of limitation under any general or special laws in respect of all judicial or quasi-judicial proceedings.
    IndiaTax
    Khaitan & Co.
    Khaitan & Co.
  • Article

    Abraxene’s Consecutive Rebuttal By Indian Patent Office

    Abraxene is an injectible formulation of protein bound particles (paclitaxel) primarily used in the treatment of breast cancer, lung cancer and pancreatic cancer.
    IndiaIntellectual Property
    S&A Law Offices
    S&A Law Offices
  • Article

    An Overview On Patenting Of Medical Procedures

    The patentability of medical procedures is a topic that has been subject to debate since several years.
    IndiaIntellectual Property
    Khurana & Khurana, Advocates and IP Attorneys
    Khurana & Khurana, Advocates and IP Attorneys
  • Article

    Department Of Pharmaceuticals (DoP) Releases Draft Guidelines For Public Procurement Of Medical Devices

    On March 15, 2018, the Department of Pharmaceuticals, Ministry of Chemicals and Fertilizers, released a draft guideline for implementation of the provisions of the Public Procurement...
    IndiaFood, Drugs, Healthcare, Life Sciences
    S&A Law Offices
    S&A Law Offices
  • Article

    Healthcare Sector Expectations From Budget 2024

    The COVID-19 pandemic put a spotlight on healthcare systems across the globe and exposed areas of improvement within the system.
    IndiaFood, Drugs, Healthcare, Life Sciences
    Nexdigm Private Limited
    Nexdigm Private Limited
  • Article

    Lifesciences And Healthcare In 2020: Year-in-Review

    As the COVID-19 pandemic continues, the pharmaceutical sector has adapted to major, fast-moving changes.
    IndiaFood, Drugs, Healthcare, Life Sciences
    Khaitan & Co.
    Khaitan & Co.
  • Article

    Medical Devices: Compliances And Regulations In India

    There are around 800 producers of pharmaceutical goods and devices in India, and the country's market is the fourth largest in Asia.
    IndiaFood, Drugs, Healthcare, Life Sciences
    Khurana & Khurana, Advocates and IP Attorneys
    Khurana & Khurana, Advocates and IP Attorneys
  • Article

    Regulatory Yearly Wrap 2021: Healthcare In India

    The past year has seen some significant developments in the healthcare sector in India. The passage of a new law to provide standards for education and services performed by allied and healthcare professions...
    IndiaFood, Drugs, Healthcare, Life Sciences
    Nishith Desai Associates
    Nishith Desai Associates
  • Article

    Delhi High Court Grants Temporary Injunction Against Macleods Pharmaceuticals Ltd

    In a recent case decided by the Delhi High Court, Justice R.K.Gauba granted temporary injunction in favor of Intas Pharmaceuticals Ltd restraining the use of its trademark by the Macleods Pharmaceuticals Ltd.
    IndiaIntellectual Property
    S.S. Rana & Co.
    S.S. Rana & Co.
  • Showing 241–260 of 442 results

    PreviousNext
    Legal Intelligence Newsletters: sign up for the latest legal and regulatory news on your chosen topics